Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RNA
RNA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RNA News
Atrium Therapeutics Secures $15 Million Milestone Payment from Bristol Myers Squibb
Apr 23 2026
NASDAQ.COM
Atrium Therapeutics Grants Stock Options to New Hires
Apr 21 2026
Newsfilter
Atrium Therapeutics Grants Stock Options to New Hires
Apr 21 2026
PRnewswire
Atrium Therapeutics Launches as Independent Company Advancing Precision Cardiology
Feb 27 2026
PRnewswire
Atrium Therapeutics Launches as Independent Company Advancing Precision Cardiology
Feb 27 2026
Newsfilter
Applied Optoelectronics Reports Strong Q4, Shares Surge
Feb 27 2026
Benzinga
Avidity Biosciences Reports Del-desiran Clinical Trial Results
Feb 18 2026
PRnewswire
Avidity Biosciences Reports Del-desiran Clinical Trial Results
Feb 18 2026
Newsfilter
Avidity Biosciences Announces Share Distribution for Spin-Off
Feb 03 2026
Newsfilter
Avidity Biosciences Announces Spin-Off Plan
Feb 03 2026
PRnewswire
Halper Sadeh LLC Investigates Multiple Companies for Securities Violations
Jan 31 2026
Globenewswire
Earnings Momentum Review: BAX and Others Rated D
Jan 16 2026
seekingalpha
Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84%
Dec 31 2025
Benzinga
Two Health Care Stocks That Could Cause You Concern This December
Dec 16 2025
Benzinga
ETF Outflow Warning: XBI, EXAS, RVMD, RNA
Dec 11 2025
NASDAQ.COM
Oppenheimer Upgrades Dyne Ahead of Avidity's Upcoming Trial Results
Dec 10 2025
SeekingAlpha
Show More News
